0

Pharmacokinetics of Total Thyroxine After Repeated Oral Administration of Levothyroxine Solution and Its Clinical Efficacy in Hypothyroid Dogs

I C van Dijl, G Le Traon, B D A M van de Meulengraaf, S Burgaud, L J I Horspool, H S Kooistra

J Vet Intern Med. Jul-Aug 2014;28(4):1229-34.

PMID: 24773132

Abstract:

Background:
Oral levothyroxine (l-T4 ) supplementation is commonly used to treat hypothyroid dogs.
Objectives:
Investigate the plasma profile and pharmacokinetics of total thyroxine (tT4 ) after PO administration of a l-T4 solution and its clinical efficacy in hypothyroid dogs.
Animals:
Ten dogs with naturally occurring hypothyroidism.
Methods:
After hypothyroidism diagnosis and supplementation with l-T4 solution PO q24h at 20 μg/kg BW for minimum 4 weeks, the plasma profile and pharmacokinetics of tT4 were determined over 34 hours and the clinical condition of the dogs was evaluated.
Results:
Before dosing for pharmacokinetic evaluation, mean tT4 concentration was 23 ± 9 nmol/L. l-T4 was absorbed rapidly (tmax , 5 hours), reaching a mean maximal tT4 concentration of 56 ± 11 nmol/L. The apparent terminal half-life was 11.8 hours. Clinical signs of hypothyroidism improved or resolved in all dogs after 4 weeks of treatment. The dosage of 20 μg/kg PO q24h was judged appropriate in 5 dogs, and 4 dogs required slight increases (9-16%). Twice daily treatment, with a 30% increase in dosage, was necessary for 1 dog.
Conclusions and clinical importance:
The pharmacokinetics of l-T4 in hypothyroid dogs was similar to that reported in healthy euthyroid dogs. Clinical and hormonal responses to l-T4 solution were rapid in all dogs. The starting dosage of 20 μg/kg PO q24h was suitable for maintenance supplementation in 50% of the dogs, minor dosage modification was required in 4 other dogs, and treatment q12h was required in 1 dog.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP51489-A L-Thyroxine (T4) solution L-Thyroxine (T4) solution 51-48-9 Price
qrcode